OSGIN2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.654200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.868400E-01
Normal-vs-Stage2
9.025400E-01
Normal-vs-Stage3
1.570760E-01
Normal-vs-Stage4
6.916200E-01
Stage1-vs-Stage2
8.920600E-01
Stage1-vs-Stage3
2.428000E-01
Stage1-vs-Stage4
4.695800E-01
Stage2-vs-Stage3
2.966400E-01
Stage2-vs-Stage4
6.241600E-01
Stage3-vs-Stage4
5.661800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.735200E-01
Normal-vs-AfricanAmerican
9.021800E-01
Normal-vs-Asian
4.092200E-01
Caucasian-vs-AfricanAmerican
9.796800E-01
Caucasian-vs-Asian
3.816400E-01
AfricanAmerican-vs-Asian
4.983600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.669200E-01
Normal-vs-Female
8.784200E-01
Male-vs-Female
9.885000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.103200E-01
Normal-vs-Age(41-60Yrs)
7.196400E-01
Normal-vs-Age(61-80Yrs)
6.727800E-01
Normal-vs-Age(81-100Yrs)
5.144800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.906600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.588800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.683800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.736300E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.199220E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.801200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.144600E-01
Normal-vs-Daily Drinker
3.824400E-01
Normal-vs-Weekly Drinker
4.034600E-01
Normal-vs-Occasional Drinker
6.679200E-01
Normal-vs-Social Drinker
7.320400E-01
Non Drinker-vs-Daily Drinker
5.589000E-01
Non Drinker-vs-Weekly Drinker
8.203400E-01
Non Drinker-vs-Occasional Drinker
9.552300E-02
Non Drinker-vs-Social Drinker
2.147200E-01
Daily Drinker-vs-Weekly Drinker
7.450800E-01
Daily Drinker-vs-Occasional Drinker
4.350200E-02
Daily Drinker-vs-Social Drinker
1.360800E-01
Weekly Drinker-vs-Occasional Drinker
6.860500E-02
Weekly Drinker-vs-Social Drinker
1.765350E-01
Occasional Drinker-vs-Social Drinker
9.481400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.384200E-01
Normal-vs-Grade 2
1.895160E-01
Normal-vs-Grade 3
2.463000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.698300E-02
Grade 1-vs-Grade 3
5.163900E-03
Grade 1-vs-Grade 4
4.384200E-01
Grade 2-vs-Grade 3
1.931950E-01
Grade 2-vs-Grade 4
1.895160E-01
Grade 3-vs-Grade 4
2.463000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.615800E-01
Normal-vs-NonDiabetic
8.530800E-01
Diabetic-vs-NonDiabetic
5.664800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.675800E-01
Normal-vs-NoPancreatitis
8.744600E-01
Pancreatitis-vs-NoPancreatitis
5.216200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.430800E-01
Normal-vs-N1
9.315400E-01
N0-vs-N1
5.069200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.982200E-01
Normal-vs-TP53-NonMutant
6.193800E-01
TP53-Mutant-vs-TP53-NonMutant
4.132300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
